Lisa A. Robinson, Senior Research Scientist, was appointed CHDS Deputy Director on July 1, 2020. Robinson specializes in the conduct of benefit-cost analysis, particularly for policies with outcomes that cannot be fully valued using market measures. A significant portion of her work focuses on approaches for valuing mortality risk reductions, commonly referred to as the value per statistical life (VSL).
Robinson has conducted numerous assessments of the costs, benefits, and other impacts of environmental, health, and safety policies and regulations, developed related methods, and drafted guidance documents. Recently she led the creation of benefit-cost analysis guidelines for the U.S. Department of Health and Human Services and for the Bill & Melinda Gates Foundation, focusing in the latter case on low- and middle-income countries. She has taught across Harvard on micro-economics, benefit-cost analysis, regulatory analysis, and economic evaluation more generally.
Previously, Robinson was a Senior Fellow at the Harvard Kennedy School. She is a past President of the Society for Benefit-Cost Analysis and a Fellow of the Society for Risk Analysis. She serves on the Editorial Boards of Risk Analysis and the Journal of Benefit-Cost Analysis.